Stock Quote
Advanced Cell Technology, Inc. (ACTC.OB) (OTC BB)
$0.11
3:59pm EST
+12.89%
$0.10
$0.10
13,518,932
$0.11
$0.10
$0.96
$0.01
-3.15
8,023,287
ACTC.OB
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Caldwell, William | Chairman of the Board, Chief Executive Officer | 350,995 |
| Lanza, Robert | Chief Scientific Officer | 493,873 |
| Shapiro, Alan | Director | -- |
Profile
Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the field of regenerative medicine. The Company has acquired, developed and maintain a portfolio of patents and patent applications that form the base... Full Description
Company Address
Advanced Cell Technology, Inc.
381 Plantation Street
Worcester MA 01605
P: +1510.7484900
381 Plantation Street
Worcester MA 01605
P: +1510.7484900
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Geron Corporation | $6.20 | +0.76 |
| Genzyme Corporation | $51.29 | +0.18 |
| StemCells, Inc. | $1.48 | +0.40 |
| ACTC.OB | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.95 |
| P/S(TTM) | 48.77 | 33.02 |
| ROI(TTM) | -- | 2.05 |
| ROE(TTM) | -- | 3.25 |
No consensus estimates data available.
| Total Revenue | $0.24M |
| Net Income | $-29.44M |
| EPS | $-0.06 |
